.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Citi
Cipla
Teva
Merck
Healthtrust
Dow
US Department of Justice
Covington
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

Imipramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for imipramine hydrochloride and what is the scope of imipramine hydrochloride patent protection?

Imipramine hydrochloride
is the generic ingredient in five branded drugs marketed by Sandoz, Leading Pharma Llc, Vangard, Watson Labs, Par Pharm, West Ward, Alra, Teva, Sanofi Aventis Us, Novartis, Lupin Ltd, Mallinckrodt Inc, Sun Pharm Inds, Oxford Pharms, Lederle, Usl Pharma, Abbott, and Roxane, and is included in forty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for imipramine hydrochloride. Twenty suppliers are listed for this compound.

Summary for Generic Name: imipramine hydrochloride

Tradenames:5
Patents:1
Applicants:18
NDAs:42
Drug Master File Entries: see list34
Suppliers / Packagers: see list20
Bulk Api Vendors: see list38
Clinical Trials: see list2,275
Patent Applications: see list1,002
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:imipramine hydrochloride at DailyMed

Pharmacology for Ingredient: imipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL084252-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL085878-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Oxford Pharms
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL040751-003Feb 28, 2008RXNoNo► Subscribe► Subscribe
Par Pharm
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL088292-001Oct 21, 1983ABRXNoNo► Subscribe► Subscribe
Lederle
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL086268-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Cipla
Colorcon
Express Scripts
Farmers Insurance
Boehringer Ingelheim
Merck
Moodys
Chubb
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot